Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Other

Global Clinical Trials

Tracked across 1 events · 6 articles · First seen Jun 03, 2026 · Last active Jun 08, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 60
Business
Sapu Nano announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection), a proprietary intravenous formulation of everolimus. The program, which initially had an Australian clinical footprint, is now expanding…
Impact: Global Clinical Trials (GCT) was appointed as the lead contract research organization for Sapu Nano's Sapu003 Phase 1b program, supporting its international expansion into Europe and other territories.
Jun 03, 2026 · 6 articles
NEWSDESK
Track Global Clinical Trials live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.